Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns

CE-MS serves as a fast and sensitive tool for identification of biomarkers and urinary polypeptide patterns specific for macroalbuminuric type 2 diabetic patients and may be used to explore and monitor renoprotective effects of ARB.